Johnson Matthey PLC (LON:JMAT - Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as GBX 1,888 ($25.51) and last traded at GBX 1,792.32 ($24.22), with a volume of 3427063 shares traded. The stock had previously closed at GBX 1,389 ($18.77).
Johnson Matthey Stock Up 0.4%
The firm's 50-day simple moving average is GBX 1,319.16 and its 200-day simple moving average is GBX 1,378.49. The company has a market capitalization of £2.86 billion, a price-to-earnings ratio of 29.06, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings data on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) EPS for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Sell-side analysts forecast that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Increases Dividend
The business also recently declared a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. The ex-dividend date was Thursday, April 10th. This is a boost from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. Johnson Matthey's payout ratio is 130.84%.
Insider Buying and Selling at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon purchased 27 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was purchased at an average price of GBX 1,445 ($19.53) per share, for a total transaction of £390.15 ($527.23). Insiders bought a total of 75 shares of company stock valued at $99,927 in the last three months. Company insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
